The results showed that expression of USP44 was lower in advanced-stage (stages IV) than in early-stage (stages II and III) HCC tumors (p = 0.049, Table 1), suggesting that USP44 expression is related to tumor staging. This evidence concerns the gene USP44 and hepatocellular carcinoma.